ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed May 3, 2016
Insider Transaction Report
Form 4
Ward Carter Julian
Chief Financial Officer
Transactions
- Conversion
Common Stock
2016-04-28$0.06/sh+666,667$41,667→ 1,752,285 total - Conversion
Warrants
2016-04-28−666,667→ 0 totalExercise: $0.06From: 2009-06-03Exp: 2016-06-03→ Common Stock (666,667 underlying)
Holdings
- 1,355,014(indirect: By IRA)
Common Stock